Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study.
Identifieur interne : 001E02 ( Ncbi/Merge ); précédent : 001E01; suivant : 001E03Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study.
Auteurs : I. Litvan [États-Unis] ; C A Mangone ; A. Mckee ; M. Verny ; A. Parsa ; K. Jellinger ; L. D'Olhaberriague ; K R Chaudhuri ; R K PearceSource :
- Journal of neurology, neurosurgery, and psychiatry [ 0022-3050 ] ; 1996.
English descriptors
- KwdEn :
- Aged, Antiparkinson Agents (administration & dosage), Antiparkinson Agents (therapeutic use), Deglutition Disorders (complications), Deglutition Disorders (therapy), Diagnosis, Differential, Diagnostic Errors, Diet Therapy, Female, Humans, Levodopa (administration & dosage), Levodopa (therapeutic use), Magnetic Resonance Imaging, Male, Medical Records, Middle Aged, Parkinson Disease (diagnosis), Pneumonia, Aspiration (etiology), Pneumonia, Aspiration (prevention & control), Supranuclear Palsy, Progressive (complications), Supranuclear Palsy, Progressive (diagnosis), Supranuclear Palsy, Progressive (drug therapy), Survival Rate, Tomography, Emission-Computed, Single-Photon, Tomography, X-Ray Computed.
- MESH :
- chemical , administration & dosage : Antiparkinson Agents, Levodopa.
- chemical , therapeutic use : Antiparkinson Agents, Levodopa.
- complications : Deglutition Disorders, Supranuclear Palsy, Progressive.
- diagnosis : Parkinson Disease, Supranuclear Palsy, Progressive.
- drug therapy : Supranuclear Palsy, Progressive.
- etiology : Pneumonia, Aspiration.
- prevention & control : Pneumonia, Aspiration.
- therapy : Deglutition Disorders.
- Aged, Diagnosis, Differential, Diagnostic Errors, Diet Therapy, Female, Humans, Magnetic Resonance Imaging, Male, Medical Records, Middle Aged, Survival Rate, Tomography, Emission-Computed, Single-Photon, Tomography, X-Ray Computed.
Abstract
OBJECTIVE--To analyse the natural history of progressive supranuclear palsy (PSP or Steele-Richardson-Olszewski syndrome) and clinical predictors of survival in 24 patients with PSP confirmed by necropsy, who fulfilled the NINDS criteria for a neuropathological diagnosis of typical PSP. METHODS--Patients were selected from the research and clinical files of seven medical centres involving tertiary centres of Austria, England, France, and the United States. Clinical features were analysed in detail. The patients' mean age at onset of PSP was 63 (range 45-73) years. RESULTS--The most frequent clinical features (occurring in at least 75% of the patients) were early postural instability and falls, vertical supranuclear palsy, akinetic-rigid predominant parkinsonian disorder characterised by symmetric bradykinesia and axial rigidity unrelieved by levodopa, pseudobulbar palsy, and frontal release signs. Occasionally, segmental dystonia or myoclonus were described, but neither aphasia nor alien limb syndrome was reported. Fractures occurred in 25% of the patients but were unrelated to the severity of the gait or to the presence of falls. Median survival time was 5.6 (range 2-16.6) years. Onset of falls during the first year, early dysphagia, and incontinence predicted a shorter survival time. Age at onset, sex, early onset of dementia, vertical supranuclear palsy, or axial rigidity had no effect on prognosis of survival. Pneumonia was the most common immediate cause of death. PSP was most often clinically misdiagnosed as Parkinson's disease. Errors in diagnosis suggest that PSP is underdiagnosed. CONCLUSION--Progressive onset of early postural instability with falls or supranuclear vertical palsy in the fifth decade, should suggest the diagnosis of PSP. Onset of falls during the first year are emphasised, as they could lead to an early diagnosis and influence the prognosis of patients with PSP. Whether appropriate treatment of the dysphagia could prolong the survival of PSP patients needs to be explored.
PubMed: 8648326
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 001576
- to stream PubMed, to step Curation: 001535
- to stream PubMed, to step Checkpoint: 001535
Links to Exploration step
pubmed:8648326Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study.</title><author><name sortKey="Litvan, I" sort="Litvan, I" uniqKey="Litvan I" first="I" last="Litvan">I. Litvan</name><affiliation wicri:level="1"><nlm:affiliation>Neuroepidemiology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Neuroepidemiology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892</wicri:regionArea><wicri:noRegion>Maryland 20892</wicri:noRegion></affiliation></author><author><name sortKey="Mangone, C A" sort="Mangone, C A" uniqKey="Mangone C" first="C A" last="Mangone">C A Mangone</name></author><author><name sortKey="Mckee, A" sort="Mckee, A" uniqKey="Mckee A" first="A" last="Mckee">A. Mckee</name></author><author><name sortKey="Verny, M" sort="Verny, M" uniqKey="Verny M" first="M" last="Verny">M. Verny</name></author><author><name sortKey="Parsa, A" sort="Parsa, A" uniqKey="Parsa A" first="A" last="Parsa">A. Parsa</name></author><author><name sortKey="Jellinger, K" sort="Jellinger, K" uniqKey="Jellinger K" first="K" last="Jellinger">K. Jellinger</name></author><author><name sortKey="D Olhaberriague, L" sort="D Olhaberriague, L" uniqKey="D Olhaberriague L" first="L" last="D'Olhaberriague">L. D'Olhaberriague</name></author><author><name sortKey="Chaudhuri, K R" sort="Chaudhuri, K R" uniqKey="Chaudhuri K" first="K R" last="Chaudhuri">K R Chaudhuri</name></author><author><name sortKey="Pearce, R K" sort="Pearce, R K" uniqKey="Pearce R" first="R K" last="Pearce">R K Pearce</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="1996">1996</date><idno type="RBID">pubmed:8648326</idno><idno type="pmid">8648326</idno><idno type="wicri:Area/PubMed/Corpus">001576</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001576</idno><idno type="wicri:Area/PubMed/Curation">001535</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001535</idno><idno type="wicri:Area/PubMed/Checkpoint">001535</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001535</idno><idno type="wicri:Area/Ncbi/Merge">001E02</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study.</title><author><name sortKey="Litvan, I" sort="Litvan, I" uniqKey="Litvan I" first="I" last="Litvan">I. Litvan</name><affiliation wicri:level="1"><nlm:affiliation>Neuroepidemiology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Neuroepidemiology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892</wicri:regionArea><wicri:noRegion>Maryland 20892</wicri:noRegion></affiliation></author><author><name sortKey="Mangone, C A" sort="Mangone, C A" uniqKey="Mangone C" first="C A" last="Mangone">C A Mangone</name></author><author><name sortKey="Mckee, A" sort="Mckee, A" uniqKey="Mckee A" first="A" last="Mckee">A. Mckee</name></author><author><name sortKey="Verny, M" sort="Verny, M" uniqKey="Verny M" first="M" last="Verny">M. Verny</name></author><author><name sortKey="Parsa, A" sort="Parsa, A" uniqKey="Parsa A" first="A" last="Parsa">A. Parsa</name></author><author><name sortKey="Jellinger, K" sort="Jellinger, K" uniqKey="Jellinger K" first="K" last="Jellinger">K. Jellinger</name></author><author><name sortKey="D Olhaberriague, L" sort="D Olhaberriague, L" uniqKey="D Olhaberriague L" first="L" last="D'Olhaberriague">L. D'Olhaberriague</name></author><author><name sortKey="Chaudhuri, K R" sort="Chaudhuri, K R" uniqKey="Chaudhuri K" first="K R" last="Chaudhuri">K R Chaudhuri</name></author><author><name sortKey="Pearce, R K" sort="Pearce, R K" uniqKey="Pearce R" first="R K" last="Pearce">R K Pearce</name></author></analytic><series><title level="j">Journal of neurology, neurosurgery, and psychiatry</title><idno type="ISSN">0022-3050</idno><imprint><date when="1996" type="published">1996</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term><term>Antiparkinson Agents (administration & dosage)</term><term>Antiparkinson Agents (therapeutic use)</term><term>Deglutition Disorders (complications)</term><term>Deglutition Disorders (therapy)</term><term>Diagnosis, Differential</term><term>Diagnostic Errors</term><term>Diet Therapy</term><term>Female</term><term>Humans</term><term>Levodopa (administration & dosage)</term><term>Levodopa (therapeutic use)</term><term>Magnetic Resonance Imaging</term><term>Male</term><term>Medical Records</term><term>Middle Aged</term><term>Parkinson Disease (diagnosis)</term><term>Pneumonia, Aspiration (etiology)</term><term>Pneumonia, Aspiration (prevention & control)</term><term>Supranuclear Palsy, Progressive (complications)</term><term>Supranuclear Palsy, Progressive (diagnosis)</term><term>Supranuclear Palsy, Progressive (drug therapy)</term><term>Survival Rate</term><term>Tomography, Emission-Computed, Single-Photon</term><term>Tomography, X-Ray Computed</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Antiparkinson Agents</term><term>Levodopa</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiparkinson Agents</term><term>Levodopa</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Deglutition Disorders</term><term>Supranuclear Palsy, Progressive</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Parkinson Disease</term><term>Supranuclear Palsy, Progressive</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Supranuclear Palsy, Progressive</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Pneumonia, Aspiration</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Pneumonia, Aspiration</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Deglutition Disorders</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Diagnosis, Differential</term><term>Diagnostic Errors</term><term>Diet Therapy</term><term>Female</term><term>Humans</term><term>Magnetic Resonance Imaging</term><term>Male</term><term>Medical Records</term><term>Middle Aged</term><term>Survival Rate</term><term>Tomography, Emission-Computed, Single-Photon</term><term>Tomography, X-Ray Computed</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">OBJECTIVE--To analyse the natural history of progressive supranuclear palsy (PSP or Steele-Richardson-Olszewski syndrome) and clinical predictors of survival in 24 patients with PSP confirmed by necropsy, who fulfilled the NINDS criteria for a neuropathological diagnosis of typical PSP. METHODS--Patients were selected from the research and clinical files of seven medical centres involving tertiary centres of Austria, England, France, and the United States. Clinical features were analysed in detail. The patients' mean age at onset of PSP was 63 (range 45-73) years. RESULTS--The most frequent clinical features (occurring in at least 75% of the patients) were early postural instability and falls, vertical supranuclear palsy, akinetic-rigid predominant parkinsonian disorder characterised by symmetric bradykinesia and axial rigidity unrelieved by levodopa, pseudobulbar palsy, and frontal release signs. Occasionally, segmental dystonia or myoclonus were described, but neither aphasia nor alien limb syndrome was reported. Fractures occurred in 25% of the patients but were unrelated to the severity of the gait or to the presence of falls. Median survival time was 5.6 (range 2-16.6) years. Onset of falls during the first year, early dysphagia, and incontinence predicted a shorter survival time. Age at onset, sex, early onset of dementia, vertical supranuclear palsy, or axial rigidity had no effect on prognosis of survival. Pneumonia was the most common immediate cause of death. PSP was most often clinically misdiagnosed as Parkinson's disease. Errors in diagnosis suggest that PSP is underdiagnosed. CONCLUSION--Progressive onset of early postural instability with falls or supranuclear vertical palsy in the fifth decade, should suggest the diagnosis of PSP. Onset of falls during the first year are emphasised, as they could lead to an early diagnosis and influence the prognosis of patients with PSP. Whether appropriate treatment of the dysphagia could prolong the survival of PSP patients needs to be explored.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">8648326</PMID><DateCreated><Year>1996</Year><Month>07</Month><Day>19</Day></DateCreated><DateCompleted><Year>1996</Year><Month>07</Month><Day>19</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0022-3050</ISSN><JournalIssue CitedMedium="Print"><Volume>60</Volume><Issue>6</Issue><PubDate><Year>1996</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Journal of neurology, neurosurgery, and psychiatry</Title><ISOAbbreviation>J. Neurol. Neurosurg. Psychiatr.</ISOAbbreviation></Journal><ArticleTitle>Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study.</ArticleTitle><Pagination><MedlinePgn>615-20</MedlinePgn></Pagination><Abstract><AbstractText>OBJECTIVE--To analyse the natural history of progressive supranuclear palsy (PSP or Steele-Richardson-Olszewski syndrome) and clinical predictors of survival in 24 patients with PSP confirmed by necropsy, who fulfilled the NINDS criteria for a neuropathological diagnosis of typical PSP. METHODS--Patients were selected from the research and clinical files of seven medical centres involving tertiary centres of Austria, England, France, and the United States. Clinical features were analysed in detail. The patients' mean age at onset of PSP was 63 (range 45-73) years. RESULTS--The most frequent clinical features (occurring in at least 75% of the patients) were early postural instability and falls, vertical supranuclear palsy, akinetic-rigid predominant parkinsonian disorder characterised by symmetric bradykinesia and axial rigidity unrelieved by levodopa, pseudobulbar palsy, and frontal release signs. Occasionally, segmental dystonia or myoclonus were described, but neither aphasia nor alien limb syndrome was reported. Fractures occurred in 25% of the patients but were unrelated to the severity of the gait or to the presence of falls. Median survival time was 5.6 (range 2-16.6) years. Onset of falls during the first year, early dysphagia, and incontinence predicted a shorter survival time. Age at onset, sex, early onset of dementia, vertical supranuclear palsy, or axial rigidity had no effect on prognosis of survival. Pneumonia was the most common immediate cause of death. PSP was most often clinically misdiagnosed as Parkinson's disease. Errors in diagnosis suggest that PSP is underdiagnosed. CONCLUSION--Progressive onset of early postural instability with falls or supranuclear vertical palsy in the fifth decade, should suggest the diagnosis of PSP. Onset of falls during the first year are emphasised, as they could lead to an early diagnosis and influence the prognosis of patients with PSP. Whether appropriate treatment of the dysphagia could prolong the survival of PSP patients needs to be explored.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Litvan</LastName><ForeName>I</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Neuroepidemiology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mangone</LastName><ForeName>C A</ForeName><Initials>CA</Initials></Author><Author ValidYN="Y"><LastName>McKee</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Verny</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Parsa</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Jellinger</LastName><ForeName>K</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>D'Olhaberriague</LastName><ForeName>L</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Chaudhuri</LastName><ForeName>K R</ForeName><Initials>KR</Initials></Author><Author ValidYN="Y"><LastName>Pearce</LastName><ForeName>R K</ForeName><Initials>RK</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Neurol Neurosurg Psychiatry</MedlineTA><NlmUniqueID>2985191R</NlmUniqueID><ISSNLinking>0022-3050</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000978">Antiparkinson Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>46627O600J</RegistryNumber><NameOfSubstance UI="D007980">Levodopa</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 1993 Oct;8(4):525-32</RefSource><PMID Version="1">8232366</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 1992 Oct;7(4):355-8</RefSource><PMID Version="1">1484531</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurology. 1994 Jun;44(6):1015-24</RefSource><PMID Version="1">8208392</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurology. 1994 Aug;44(8):1436-40</RefSource><PMID Version="1">8058145</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Brain. 1994 Aug;117 ( Pt 4):835-45</RefSource><PMID Version="1">7922469</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Brain. 1994 Oct;117 ( Pt 5):1183-96</RefSource><PMID Version="1">7953598</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neural Transm Suppl. 1994;42:119-34</RefSource><PMID Version="1">7964682</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neural Transm Suppl. 1994;42:189-201</RefSource><PMID Version="1">7964687</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neural Transm Suppl. 1994;42:93-110</RefSource><PMID Version="1">7964700</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 1994 Jul;9(4):381-9</RefSource><PMID Version="1">7969203</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurology. 1994 Nov;44(11):2015-9</RefSource><PMID Version="1">7969952</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arch Neurol. 1995 Mar;52(3):294-8</RefSource><PMID Version="1">7872884</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMJ. 1995 Feb 18;310(6977):447-52</RefSource><PMID Version="1">7646647</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurol Neurosurg Psychiatry. 1995 Feb;58(2):167-73</RefSource><PMID Version="1">7876846</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurol Neurosurg Psychiatry. 1995 Mar;58(3):293-9</RefSource><PMID Version="1">7897409</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>JAMA. 1995 May 3;273(17):1348-53</RefSource><PMID Version="1">7715059</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Brain. 1995 Jun;118 ( Pt 3):759-70</RefSource><PMID Version="1">7600092</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurol Neurosurg Psychiatry. 1995 Jun;58(6):759-60</RefSource><PMID Version="1">7608689</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurol Sci. 1995 May;130(1):104-11</RefSource><PMID Version="1">7650525</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neuropathol Exp Neurol. 1996 Jan;55(1):97-105</RefSource><PMID Version="1">8558176</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Neurol. 1985 Apr;17(4):337-43</RefSource><PMID Version="1">4004154</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 1985 Nov 14;313(20):1263-9</RefSource><PMID Version="1">4058507</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurology. 1986 Jul;36(7):1005-8</RefSource><PMID Version="1">3714047</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurology. 1987 Apr;37(4):570-6</RefSource><PMID Version="1">3561771</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurology. 1988 Jul;38(7):1031-4</RefSource><PMID Version="1">3386818</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arch Phys Med Rehabil. 1988 Aug;69(8):637-40</RefSource><PMID Version="1">3408337</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>No To Shinkei. 1993 Feb;45(2):113-8</RefSource><PMID Version="1">8476660</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arch Neurol. 1993 May;50(5):513-6</RefSource><PMID Version="1">8489409</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arch Neurol. 1964 Apr;10:333-59</RefSource><PMID Version="1">14107684</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Ophthalmol. 1972 Dec;74(6):1179-84</RefSource><PMID Version="1">4646725</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arch Neurol. 1981 Dec;38(12):784</RefSource><PMID Version="1">7316849</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ital J Neurol Sci. 1980 Oct;1(4):205-22</RefSource><PMID Version="1">7338456</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Rev Neurol (Paris). 1983;139(6-7):407-16</RefSource><PMID Version="1">6612148</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 1987;2(4):263-78</RefSource><PMID Version="1">3504554</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurol Neurosurg Psychiatry. 1988 Sep;51(9):1224-7</RefSource><PMID Version="1">3225606</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 1989 Apr 20;320(16):1055-9</RefSource><PMID Version="1">2648154</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Comput Assist Tomogr. 1989 Jul-Aug;13(4):555-60</RefSource><PMID Version="1">2745772</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Brain. 1989 Oct;112 ( Pt 5):1171-92</RefSource><PMID Version="1">2478251</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dysphagia. 1990;5(2):61-71</RefSource><PMID Version="1">2209101</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurol Neurosurg Psychiatry. 1991 May;54(5):397-400</RefSource><PMID Version="1">1865200</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Neurol. 1991 Apr;29(4):389-96</RefSource><PMID Version="1">1929210</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurol Neurosurg Psychiatry. 1991 Dec;54(12):1121-2</RefSource><PMID Version="1">1723749</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurol Neurosurg Psychiatry. 1992 Aug;55(8):707-13</RefSource><PMID Version="1">1527543</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurol Neurosurg Psychiatry. 1994 Mar;57(3):278-84</RefSource><PMID Version="1">8158173</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000978" MajorTopicYN="N">Antiparkinson Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003680" MajorTopicYN="N">Deglutition Disorders</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003951" MajorTopicYN="N">Diagnostic Errors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004035" MajorTopicYN="N">Diet Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007980" MajorTopicYN="N">Levodopa</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008499" MajorTopicYN="N">Medical Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011015" MajorTopicYN="N">Pneumonia, Aspiration</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013494" MajorTopicYN="N">Supranuclear Palsy, Progressive</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015899" MajorTopicYN="N">Tomography, Emission-Computed, Single-Photon</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014057" MajorTopicYN="N">Tomography, X-Ray Computed</DescriptorName></MeshHeading></MeshHeadingList><OtherID Source="NLM">PMC1073943</OtherID></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1996</Year><Month>6</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1996</Year><Month>6</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1996</Year><Month>6</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">8648326</ArticleId><ArticleId IdType="pmc">PMC1073943</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>États-Unis</li></country></list><tree><noCountry><name sortKey="Chaudhuri, K R" sort="Chaudhuri, K R" uniqKey="Chaudhuri K" first="K R" last="Chaudhuri">K R Chaudhuri</name><name sortKey="D Olhaberriague, L" sort="D Olhaberriague, L" uniqKey="D Olhaberriague L" first="L" last="D'Olhaberriague">L. D'Olhaberriague</name><name sortKey="Jellinger, K" sort="Jellinger, K" uniqKey="Jellinger K" first="K" last="Jellinger">K. Jellinger</name><name sortKey="Mangone, C A" sort="Mangone, C A" uniqKey="Mangone C" first="C A" last="Mangone">C A Mangone</name><name sortKey="Mckee, A" sort="Mckee, A" uniqKey="Mckee A" first="A" last="Mckee">A. Mckee</name><name sortKey="Parsa, A" sort="Parsa, A" uniqKey="Parsa A" first="A" last="Parsa">A. Parsa</name><name sortKey="Pearce, R K" sort="Pearce, R K" uniqKey="Pearce R" first="R K" last="Pearce">R K Pearce</name><name sortKey="Verny, M" sort="Verny, M" uniqKey="Verny M" first="M" last="Verny">M. Verny</name></noCountry><country name="États-Unis"><noRegion><name sortKey="Litvan, I" sort="Litvan, I" uniqKey="Litvan I" first="I" last="Litvan">I. Litvan</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001E02 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 001E02 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonFranceV1
|flux= Ncbi
|étape= Merge
|type= RBID
|clé= pubmed:8648326
|texte= Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:8648326" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \
| NlmPubMed2Wicri -a ParkinsonFranceV1
| This area was generated with Dilib version V0.6.29. |  |